Abstract
Neutralizing antibodies for Type 2 (Lansing) poliomyelitis virus were tested periodically in a group of 18 patients from whom Type 1 poliomyelitis virus was recovered. Data for homotypic neutralizing antibodies and Type 2 complement-fixing antibodies were also available on the majority of these patients. The results indicated that Type 2 neutralizing antibodies first appeared or significantly increased in titer in 11 of the 18 patients during the first 2 to 4 weeks after onset. In most patients the Type 2 neutralizing antibody either completely disappeared at 3 months (in one patient between 2 and 4 weeks) or dropped in titer, while the Type 1 or homotypic antibody persisted in high titer. These results are interpreted as indicating that the Type 1 and Type 2 poliomyelitis viruses share a common antigen, and that the heterotypic anti-body response is transitory while the homotypic neutralizing antibody persists for a longer time.
Full Text
The Full Text of this article is available as a PDF (445.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- CASALS J., OLITSKY P. K., ANSLOW R. O. A specific complement-fixation test for infection with poliomyelitis virus. J Exp Med. 1951 Aug;94(2):123–137. doi: 10.1084/jem.94.2.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CASALS J., OLITSKY P. K., SABIN A. B. Development, persistence, and significance of type 2, poliomyelitis complement-fixing antibody in man. J Exp Med. 1952 Jul;96(1):35–53. doi: 10.1084/jem.96.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CLARK E. M., RHODES A. J. Poliomyelitis in Canadian Eskimos, laboratory studies. II. Can J Med Sci. 1951 Aug;29(4):216–235. doi: 10.1139/cjms51-027. [DOI] [PubMed] [Google Scholar]
- HAMMON W. M., ROBERTS E. C. Serum neutralizing antibodies to the infecting strain of virus in poliomyelitis patients. Proc Soc Exp Biol Med. 1948 Nov;69(2):256–258. doi: 10.3181/00379727-69-16682. [DOI] [PubMed] [Google Scholar]
- LAHELLE O. Complement-fixation test for the Lansing strain of poliomyelitis virus. Am J Hyg. 1951 Nov;54(3):391–401. doi: 10.1093/oxfordjournals.aje.a119494. [DOI] [PubMed] [Google Scholar]
- POLLARD M., HSIANG C. M., SHARP G. R. Preparation of specific complement-fixing antigens from the three prototypes of poliomyelitis viruses. Proc Soc Exp Biol Med. 1952 Jan;79(1):48–50. doi: 10.3181/00379727-79-19268. [DOI] [PubMed] [Google Scholar]
- STEIGMAN A. J., SABIN A. B. Antibody response of patients with poliomyelitis to virus recovered from their own alimentary tract. J Exp Med. 1949 Oct;90(4):349–372. doi: 10.1084/jem.90.4.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SVEDMYR A., ENDERS J. F., HOLLOWAY A. Complement fixation with Brunhilde and Lansing poliomyelitis viruses propagated in tissue culture. Proc Soc Exp Biol Med. 1952 Feb;79(2):296–300. doi: 10.3181/00379727-79-19357. [DOI] [PubMed] [Google Scholar]
- TURNER T. B., HOLLANDER D. H., BUCKLEY S., KOKKO U. P., WINSOR C. P. Age incidence and seasonal development of neutralizing antibodies to lansing poliomyelitis virus. Am J Hyg. 1950 Nov;52(3):323–347. doi: 10.1093/oxfordjournals.aje.a119427. [DOI] [PubMed] [Google Scholar]